Skip to main content
Taylor & Francis Group Logo
Advanced Search

Click here to search books using title name,author name and keywords.

  • Login
  • Hi, User  
    • Your Account
    • Logout
Advanced Search

Click here to search books using title name,author name and keywords.

Breadcrumbs Section. Click here to navigate to respective pages.

Book

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

Book

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

DOI link for Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing book

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

DOI link for Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing book

ByHarry Yang
Edition 1st Edition
First Published 2016
eBook Published 8 December 2016
Pub. Location New York
Imprint Chapman and Hall/CRC
DOI https://doi.org/10.1201/9781315371726
Pages 386
eBook ISBN 9781315371726
Subjects Bioscience, Medicine, Dentistry, Nursing & Allied Health
Share
Share

Get Citation

Yang, H. (2016). Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (1st ed.). Chapman and Hall/CRC. https://doi.org/10.1201/9781315371726

ABSTRACT

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

TABLE OF CONTENTS

part |2 pages

Section I Background

chapter 1|18 pages

Quality by Design in Biopharmaceuticals

part |2 pages

Section II Analytical Method

chapter 2|28 pages

Analytical Method Validation

chapter 3|30 pages

Parallelism Testing of Bioassay

chapter 4|32 pages

Validation of Method Linearity

part |2 pages

Section III Process Development

chapter 5|28 pages

Residual Host Cell DNA Risk Assessment

chapter 6|18 pages

Evaluations of Viral Clearance

chapter 7|32 pages

Bioburden Testing and Control

chapter 8|30 pages

Process Validation

part |2 pages

Section IV Manufacturing

chapter 9|28 pages

Specifications

chapter 10|26 pages

Environmental Monitoring

chapter 11|34 pages

Stability Design and Analysis

chapter 12|22 pages

Investigation of Out-of-Specification and Out-of-Trend Results

T&F logoTaylor & Francis Group logo
  • Policies
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
  • Journals
    • Taylor & Francis Online
    • CogentOA
    • Taylor & Francis Online
    • CogentOA
  • Corporate
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
  • Help & Contact
    • Students/Researchers
    • Librarians/Institutions
    • Students/Researchers
    • Librarians/Institutions
  • Connect with us

Connect with us

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG © 2021 Informa UK Limited